Follow
Paul Quax
Paul Quax
Leiden University Medical Center, the Netherlands
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity
R Vogels, D Zuijdgeest, R van Rijnsoever, E Hartkoorn, I Damen, ...
Journal of virology 77 (15), 8263-8271, 2003
5622003
Consensus guidelines for the use and interpretation of angiogenesis assays
P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ...
Angiogenesis 21, 425-532, 2018
5192018
Pericellular proteases in angiogenesis and vasculogenesis
VWM van Hinsbergh, MA Engelse, PHA Quax
Arteriosclerosis, thrombosis, and vascular biology 26 (4), 716-728, 2006
5052006
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction
L Timmers, JPG Sluijter, JK van Keulen, IE Hoefer, MGJ Nederhoff, ...
Circulation research 102 (2), 257-264, 2008
4162008
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind†…
YH Kusumanto, V Van Weel, NH Mulder, AJ Smit, J Van Den Dungen, ...
Human gene therapy 17 (6), 683-691, 2006
4102006
Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells
ADV Oorschot, DF Fischer, JM Grimbergen, B Klein, SM Zhuang, ...
Proceedings of the National Academy of Sciences 94 (11), 5843-5847, 1997
4061997
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP‐stimulated bone formation
RL Van Bezooijen, JP Svensson, D Eefting, A Visser, G van der Horst, ...
Journal of Bone and Mineral Research 22 (1), 19-28, 2007
3902007
Restenosis after PCI. Part 1: pathophysiology and risk factors
JW Jukema, JJW Verschuren, TAN Ahmed, PHA Quax
Nature Reviews Cardiology 9 (1), 53-62, 2012
3492012
In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions
A Vink, AH Schoneveld, JJ van der Meer, BJ van Middelaar, JPG Sluijter, ...
Circulation 106 (15), 1985-1990, 2002
3402002
Antagomir‐mediated silencing of endothelial cell specific microRNA‐126 impairs ischemia‐induced angiogenesis
C van Solingen, L Seghers, R Bijkerk, JMGJ Duijs, MK Roeten, ...
Journal of cellular and molecular medicine 13 (8a), 1577-1585, 2009
3272009
Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease
MJE Havenga, AAC Lemckert, O Ophorst, M Van Meijer, WTV Germeraad, ...
Journal of virology 76 (9), 4612-4620, 2002
2782002
Toll-like receptor 4 is involved in outward arterial remodeling
SCG Hollestelle, MR De Vries, JK Van Keulen, AH Schoneveld, A Vink, ...
Circulation 109 (3), 393-398, 2004
2732004
Vein graft failure: from pathophysiology to clinical outcomes
MR De Vries, KH Simons, JW Jukema, J Braun, PHA Quax
Nature Reviews Cardiology 13 (8), 451-470, 2016
2702016
Drug-eluting stents: results, promises and problems
BL Van der Hoeven, NMM Pires, HM Warda, PV Oemrawsingh, ...
International journal of cardiology 99 (1), 9-17, 2005
2572005
Epigenetics in atherosclerosis and inflammation
RJ Wierda, SB Geutskens, JW Jukema, PHA Quax, PJ van den Elsen
Journal of cellular and molecular medicine 14 (6a), 1225-1240, 2010
2142010
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix
A Collen, R Hanemaaijer, F Lupu, PHA Quax, N van Lent, J Grimbergen, ...
Blood, The Journal of the American Society of Hematology 101 (5), 1810-1817, 2003
2132003
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
D Pons, FR de Vries, PJ van den Elsen, BT Heijmans, PHA Quax, ...
European heart journal 30 (3), 266-277, 2009
1992009
Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development
V Van Weel, REM Toes, L Seghers, MML Deckers, MR De Vries, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (11), 2310-2318, 2007
1922007
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
TJ de Vries, PH Quax, M Denijn, KN Verrijp, JH Verheijen, HW Verspaget, ...
The American journal of pathology 144 (1), 70, 1994
1881994
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
PH Quax, GN Van Muijen, EJ Weening-Verhoeff, LR Lund, K DanÝ, ...
The Journal of cell biology 115 (1), 191-199, 1991
1881991
The system can't perform the operation now. Try again later.
Articles 1–20